Appointment of a new Director to the Board of Directors of Immune Biosolutions Inc.

We are thrilled to welcome a new director to the board of directors of Immune Biosolutions Inc: Mr. Nicholas Franco. The arrival of Mr. Franco is part of the company’s development strategy. With over 32 years of experience in the pharmaceutical industry, research, marketing, sales, and business development in several therapeutic areas, both domestically and internationally, “He will certainly bring a unique strategic perspective of the industry and a vision focused on value creation to the Board,” says Luc Paquet, CEO of the company.

NewsGuest UserMay 1, 2023BIOOQuébecImmune Biosolutions, Board of directors

New Board of Directors Appointments for Immune Biosolutions

Immune Biosolutions, an early-stage biopharmaceutical company focusing on the discovery, engineering and development of therapeutic humanized chicken antibodies, today announced the appointments of Drs. Nadine Beauger and Louise Proulx to its Board of Directors.

NewsGuest UserJanuary 22, 2020chicken antibodies, Board of directors, Immune Biosolutions

A Woman to Lead the Génome Québec Board of Directors

A woman will be at the helm of the Génome Québec Board of Directors for the first time since the organization’s inception in 2000. Congratulations to Anie Perrault, LL.L, ASC, for her nomination.

NewsGuest UserMarch 19, 2019BIOOQuébecGénome Québec, Anie Perrault, Board of directors

Four New Administrators on BIOQuébec's Board

BIOQuébec’s Board of Directors Enhances Its Support of the Strategic Development of Québec’s Biotechnology and Life Sciences Network

press releaseGuest UserOctober 13, 2017Board of directors

GRUM’S 3rd Scientific Symposium

Pierre Falardeau, VP of BIOQuébec’s Board of Directors, will be a lecturer at GRUM’s 3rd Scientific Symposium.